Chris Rallis - Mar 3, 2023 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
Director
Signature
/s/ Chris A. Rallis
Stock symbol
FENC
Transactions as of
Mar 3, 2023
Transactions value $
-$9,791
Form type
4
Date filed
3/3/2023, 04:35 PM
Previous filing
Nov 17, 2022
Next filing
Apr 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FENC Common Shares Options Exercise $10K +4.17K +13.88% $2.40 34.2K Mar 3, 2023 Direct F1
transaction FENC Common Shares Tax liability -$19.8K -2.18K -6.36% $9.09 32.1K Mar 3, 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents options granted April 3, 2013, with a $2.40 USD strike price and expiration of April 3, 2023.
F2 Represents shares automatically sold pursuant to a 10b5-1 plan to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the exercise of 4,166 shares from an April 3, 2013 grant.